Belgium

5 Vaccines Approved for Use in Belgium

Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
15 trials in 12 countries
Approval Source: ema.europa.eu
RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
Approval Source: ema.europa.eu
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Approval Source: ema.europa.eu

5 in Clinical Trials in Belgium

Protein Subunit

Clover

SCB-2019

12 trials in 11 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

ReiThera

GRAd-COV2

5 trials in 12 countries
Protein Subunit

OSE Immunotherapeutics

CoVepiT

3 Vaccines with Trials in Belgium are No Longer Progressing

RNA

Curevac

CVnCoV

9 trials in 12 countries
Replicating Viral Vector

Institut Pasteur

COVID-19-101

Replicating Viral Vector

Merck Sharp & Dohme Corp

V591

2 trials in 3 countries